Screening compound: InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2

Screening compound: InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2
Screening compound: InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T636-1878

Molecular Formula

C19H19N5O (C19 H19 N5 O)

Compound Name

4-(4-{5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}piperazine-1-carbonyl)benzonitrile

IUPAC name

4-(4-{5H6H7H-cyclopenta[d]pyrimidin-4-yl}piperazine-1-carbonyl)benzonitrile

SMILES

N#Cc(cc1)ccc1C(N(CC1)CCN1c1ncnc2c1CCC2)=O

MDL Number (MFCD)

InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2?
Check Price and Availability of InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H19N5O/c20-12-14-4-6-15(7-5-14)19(25)24-10-8-23(9-11-24)18-16-2-1-3-17(16)21-13-22-18/h4-7,13H,1-3,8-11H2 available by request